Crossmark

Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria

Crossref DOI link: https://doi.org/10.1007/s10157-018-1585-z

Published Online: 2018-05-14

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Jianni

Lin, Li

Xie, Jingyuan

Li, Xiao

Shen, Pingyan

Pan, Xiaoxia

Ren, Hong

Chen, Nan
Funding

Funding for this research was provided by:

National Key Research and Development Program of China (2016YFC0904100)

National Natural Science Foundation of China (No. 81570598)

Shanghai Natural Science Foundation (15ZR1426300)
License Information

Text and Data Mining valid from 2018-05-14
More Information

Article History

Received: 9 February 2018

Accepted: 26 April 2018

First Online: 14 May 2018

Compliance with ethical standards

:

: All the authors have declared no competing interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Ruijin Hospital [(2017) Clinical Ethics Approval No. (154)] and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.